Minsoo Chun
Papers
2
Total Citations
23
H-Index
2
About
Minsoo Chun is a radiation oncology physicist whose work centers on advancing the precision and safety of stereotactic ablative radiotherapy (SABR) and MR-guided radiation therapy. His most cited study, published in 2017, established a rigorous gamma analysis criterion of 2%/1 mm for SABR delivered with volumetric modulated arc therapy (VMAT), demonstrating that this tighter tolerance is clinically feasible for ensuring dose delivery accuracy in high-precision treatments—a contribution that has garnered 14 citations and informed quality assurance protocols. In a companion study, Chun led a treatment plan comparison between Tri-Co-60 MR-guided radiation therapy and VMAT for prostate cancer, showing that MR-guided systems can achieve comparable target coverage while potentially reducing doses to organs at risk, a finding with 9 citations that supports the adoption of adaptive, image-guided approaches. Based at Seoul National University Hospital and the Institute of Radiation Medicine, Chun’s work bridges technological innovation and clinical application, providing evidence that helps radiation oncologists and medical physicists optimize treatment planning for complex cases. His research is particularly valuable for students and clinicians seeking to understand how advanced delivery techniques and stringent quality metrics can improve outcomes in modern radiotherapy.
Research Focus
Key Achievements
Top Papers
- 1
- 2